SYDNEY , Nov. 6, 2025 /PRNewswire/ -- Lumonus, a leader in AI powered radiation oncology workflow solutions, today announced the close of its A$25 million Series B financing round. The round was led by Aviron Investment Management with continued participation from Oncology Ventures.

This funding highlights the strong clinical adoption of Lumonus AI, with leading health systems across the United States, Australia, and Europe who are already integrating the platform into routine clinical care. To date, the Lumonus AI platform has supported clinicians in consulting and prescribing over 280,000 cancer treatments and has automated the creation of over 75,000 cancer treatment plans, demonstrating its impact in streamlining critical oncology workflows and improving the efficiency and consiste

See Full Page